By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discover today said it is collaborating with the Rosalind Franklin University of Medical Sciences to develop a human cellular disease model of cystic fibrosis.

The deal covers use of Horizon's Genesis precision genome editing technology to "reconstitute a specific mutation" in the cystic fibrosis transmembrane conductance regulator, or CFTR, protein in the endogenous genome of a lung cancer cell line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.